O
Oric Pharmaceuticals D
D
ORIC
12.670
USD
-0.12
(-0.90%)
قبل الجلسة
حجم التداول
403
الربح لكل سهم
-2
العائد الربحي
-
P/E
-10
حجم السوق
1,313,279,152
المقالات
العنوان: Oric Pharmaceuticals
القطاع: الرعاية الصحية
الصناعة: Biotechnology
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.






